Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193039 | SCV000248418 | uncertain significance | not specified | 2014-09-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000954027 | SCV001938038 | benign | not provided | 2021-05-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002057007 | SCV002490575 | benign | Schuurs-Hoeijmakers syndrome | 2022-11-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002426927 | SCV002729176 | benign | Inborn genetic diseases | 2018-11-29 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000954027 | SCV004136959 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | PACS1: BP4, BP7 |
Prevention |
RCV003977520 | SCV004793025 | likely benign | PACS1-related disorder | 2024-01-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |